A digital illustration of a DNA double helix made up of blue and green spheres against a pink background.

Advancing Health Through Innovative Research

next generation sequencing

The Beggs Lab is engaged in innovative research in cancer genetics, genomics, cancer organoid models, and omics technology. Our main focus is on colorectal, oesophageal, lung cancers, and sarcomas.

The lab is involved in method development, including long-read sequecning of the HLA comples, SNP allele sensing, and RNA amplification.

Operating a next-generation sequencing facility, we offer translational scientific analysis for academic and commercial research and clinical trials.

A grid of colorful LED lights arranged in a pattern of small squares, displaying a vibrant mosaic of green, yellow, and red colors on a black background.

our services

Empowering discovery through cutting-edge genomics and trusted diagnostics. Where innovation meets precision.

Unlock the power of precision with our advanced Next Generation Sequencing (NGS) services.

Laboratory workspace with scientific equipment, including computers, test tubes, and lab supplies.

genomics birmingham

Driving breakthroughs with cutting-edge genomic sequencing

Unlock the power of precision with our advanced Next Generation Sequencing (NGS) services. We offer comprehensive solutions including targeted panel and whole exome sequencing, RNA library preparation, methylation arrays, single-cell sequencing, and nanopore sequencing.

Designed for research and clinical applications, our services deliver high-quality, reliable data to accelerate your discoveries and innovations.

Comprehensive Solutions: From targeted panels to single-cell sequencing, tailored to your research needs.
High Accuracy & Reliability: Advanced technology ensures precise and reproducible results.
Flexible Applications: Ideal for both clinical and research environments.
Expert Support: Guidance from experienced professionals throughout your project.

Laboratory workbench with medical supplies and equipment, shelves stocked with boxes, bottles, and chemical containers, some labeled 'Evolution One' and 'HyPure Ly', a yellow hazard warning sign indicating flammable materials, and various lab tools and devices on the counter.

Diagnostic Services

Trusted diagnostics for critical research decisions.

Ensure accuracy and compliance with our Public Health England-approved diagnostic testing for SARS-CoV-2 (COVID-19). Our service supports UK NHS patients and other organizations, offering sample inactivation, RNA extraction, real-time PCR, and comprehensive data analysis for reliable coronavirus detection.

Approved & Reliable: Public Health England-certified testing for SARS-CoV-2.
Comprehensive Workflow: From sample inactivation to data analysis for complete accuracy.
Serving Healthcare & Research: Available to NHS and UK-based organizations.
Rapid & Precise Results: Real-time PCR ensures timely and dependable outcomes.

meet professor andrew beggs

“My mission is to improve cancer outcomes through science, technology, and collaboration.”

I am Professor of Cancer Genetics & Surgery at the University of Birmingham, combining clinical practice with research to transform cancer care. With over 20 years’ experience in surgery, I lead a team of 50+ scientists using advanced genomics and organoid models to tackle two critical challenges:

Why does cancer become resistant to treatment?
How can we overcome it?

As Deputy Director of the Birmingham CRUK Experimental Cancer Centre, Alan Turing Fellow, and MRC Senior Clinical Fellow, I drive innovation in precision medicine. My leadership spans national cancer genomics strategy for 15M people, NHS AI programmes, and advisory roles for biotech companies.

I have published in Nature, Cell, and The Lancet, secured major funding from MRC, Wellcome Trust, and CRUK, and contribute to global research networks.